We conducted a retrospective review of children tested for Mycoplasma pneumoniae from January 1, 2020-June 30, 2024. M. pneumoniae PCR positivity increased starting in November 2023, peaking at 18.3% in June 2024. During the resurgence, children with laboratory-confirmed infection often had severe respiratory disease or extrapulmonary manifestations.
Keywords: Mycoplasma pneumoniae; atypical pneumonia; epidemiology; reactive infectious mucocutaneous eruption; walking pneumonia.
© The Author(s) 2024. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.